Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-25-105353

Director sold 4,872 shares at $8.75 ($42,630)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

TAKANASHI KEN · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-05 Sale : show line 1 in the form 10b5-1 −4,872 $8.75 $42,630 5,716,303 D
Open-market sales · 4,872 sh · avg $8.75 · $42,630
Loading xslF345X05/ownership.xml…